Charge-Rich Regions Modulate the Anti-Aggregation Activity of Hsp90

Journal of Molecular Biology

Volumn 401, Issue 5, 2010, Pages 931-939

  Wayne, Natalie ^a   Bolon, Daniel N ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aggregation; Chaperone; Charge; Hsp90; Misfolding

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 90;

AMINO ACID SEQUENCE; AQUEOUS SOLUTION; ARTICLE; CELL FUNCTION; HUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 77955551442     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.06.066     Document Type: Article

References (43)

1. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10:S10-S17.
2. Powers E.T., Morimoto R.I., Dillin A., Kelly J.W., Balch W.E. Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 2009, 78:959-991.
3. Chaudhuri T.K., Paul S. Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J. 2006, 273:1331-1349.
4. Gao X., Hu H. Quality control of the proteins associated with neurodegenerative diseases. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:612-618.
5. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
6. Gregersen N., Bolund L., Bross P. Protein misfolding, aggregation, and degradation in disease. Mol. Biotechnol. 2005, 31:141-150.
7. Dill K.A. Dominant forces in protein folding. Biochemistry 1990, 29:7133-7155.
8. Dobson C.M. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 2004, 15:3-16.
9. Schmittschmitt J.P., Scholtz J.M. The role of protein stability, solubility, and net charge in amyloid fibril formation. Protein Sci. 2003, 12:2374-2378.
10. Zhang Y., Howitt J., McCorkle S., Lawrence P., Springer K., Freimuth P. Protein aggregation during overexpression limited by peptide extensions with large net negative charge. Protein Expression Purif. 2004, 36:207-216.
11. Lawrence M.S., Phillips K.J., Liu D.R. Supercharging proteins can impart unusual resilience. J. Am. Chem. Soc. 2007, 129:10110-10112.
12. Hartl F.U., Hayer-Hartl M. Converging concepts of protein folding in vitro and in vivo. Nat. Struct. Mol. Biol. 2009, 16:574-581.
13. Liberek K., Lewandowska A., Zietkiewicz S. Chaperones in control of protein disaggregation. EMBO J. 2008, 27:328-335.
14. Lee S., Tsai F.T. Molecular chaperones in protein quality control. J. Biochem. Mol. Biol. 2005, 38:259-265.
15. Young J.C., Agashe V.R., Siegers K., Hartl F.U. Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 2004, 5:781-791.
16. Feder M.E., Hofmann G.E. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu. Rev. Physiol. 1999, 61:243-282.
17. Xu Z., Horwich A.L., Sigler P.B. The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature 1997, 388:741-750.
18. Sigler P.B., Xu Z., Rye H.S., Burston S.G., Fenton W.A., Horwich A.L. Structure and function in GroEL-mediated protein folding. Annu. Rev. Biochem. 1998, 67:581-608.
19. Pearl L.H., Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu. Rev. Biochem. 2006, 75:271-294.
20. Mayer M.P., Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell. Mol. Life Sci. 2005, 62:670-684.
21. Kumsta C., Jakob U. Redox-regulated chaperones. Biochemistry 2009, 48:4666-4676.
22. Jakob U., Lilie H., Meyer I., Buchner J. Transient interaction of Hsp90 with early unfolding intermediates of citrate synthase. Implications for heat shock in vivo. J. Biol. Chem. 1995, 270:7288-7294.
23. Evans C.G., Wisen S., Gestwicki J.E. Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J. Biol. Chem. 2006, 281:33182-33191.
24. Muller L., Schaupp A., Walerych D., Wegele H., Buchner J. Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures. J. Biol. Chem. 2004, 279:48846-48854.
25. Youker R.T., Walsh P., Beilharz T., Lithgow T., Brodsky J.L. Distinct roles for the Hsp40 and Hsp90 molecular chaperones during cystic fibrosis transmembrane conductance regulator degradation in yeast. Mol. Biol. Cell 2004, 15:4787-4797.
26. Wiech H., Buchner J., Zimmermann R., Jakob U. Hsp90 chaperones protein folding in vitro. Nature 1992, 358:169-170.
27. Yonehara M., Minami Y., Kawata Y., Nagai J., Yahara I. Heat-induced chaperone activity of HSP90. J. Biol. Chem. 1996, 271:2641-2645.
28. Scheibel T., Buchner J. The Hsp90 complex-a super-chaperone machine as a novel drug target. Biochem. Pharmacol. 1998, 56:675-682.
29. Howson R., Huh W.K., Ghaemmaghami S., Falvo J.V., Bower K., Belle A., et al. Construction, verification and experimental use of two epitope-tagged collections of budding yeast strains. Comp. Funct. Genomics 2005, 6:2-16.
30. Freeman B.C., Morimoto R.I. The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J. 1996, 15:2969-2979.
31. Ali M.M.U., Roe S.M., Vaughan C.K., Meyer P., Panaretou B., Piper P.W., et al. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 2006, 440:1013-1017.
32. Louvion J.F., Warth R., Picard D. Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction functions in yeast. Proc. Natl Acad. Sci. USA 1996, 93:13937-13942.
33. Hainzl O., Lapina M.C., Buchner J., Richter K. The charged linker region is an important regulator of Hsp90 function. J. Biol. Chem. 2009, 284:22559-22567.
34. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003, 31:3784-3788.
35. Qu B.H., Thomas P.J. Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 1996, 271:7261-7264.
36. Scheibel T., Siegmund H.I., Jaenicke R., Ganz P., Lilie H., Buchner J. The charged region of Hsp90 modulates the function of the N-terminal domain. Proc. Natl Acad. Sci. 1999, 96:1297-1302.
37. Meyer P., Prodromou C., Hu B., Vaughan C., Roe S.M., Panaretou B., et al. Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions. Mol. Cell 2003, 11:647-658.
38. Tsutsumi S., Mollapour M., Graf C., Lee C.T., Scroggins B.T., Xu W., et al. Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain. Nat. Struct. Mol. Biol. 2009, 16:1141-1147.
39. Wayne N., Lai Y., Pullen L., Bolon D.N. Modular control of cross-oligomerization: analysis of superstabilized Hsp90 homodimers in vivo. J. Biol. Chem. 2010, 285:234-241.
40. r 83,000 heat shock protein has a homologue in Escherichia coli. Proc. Natl Acad. Sci. USA 1987, 84:5177-5181.
41. Wayne N., Bolon D.N. Dimerization of Hsp90 is required for in vivo function. Design and analysis of monomers and dimers. J. Biol. Chem. 2007, 282:35386-35395.
42. Bolon D.N., Grant R.A., Baker T.A., Sauer R.T. Specificity versus stability in computational protein design. Proc. Natl Acad. Sci. USA 2005, 102:12724-12729.
43. +-ATPase activity. Methods Enzymol. 1988, 156:116-119.